Nanoparticle albumin-bound (nab) paclitaxel in combination with nivolumab as treatment of recurrent or metastatic head and neck squamous-cell carcinoma (RM-HNSCC) that progressed on a PD-1 inhibitor: A single-arm, phase 2 trial.Jared Cohen, Douglas R. Adkins, Sarah Pennock et al.|Journal of Clinical Oncology|2023Cited by 3
Phase 2 trial of three schedules of CUE-101 administered before surgery or chemoradiotherapy in HLA-A*0201 positive patients with HPV16+ OPSCC.Jesse M. Zaretsky, Douglas Adkins, Jessica Ley et al.|Journal of Clinical Oncology|2023Cited by 2